Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Gilead’s Trodelvy Wins In TROPiCS-02, But Commercial Headwinds Remain
Aug 15 2022
•
By
Alaric DeArment
Gilead announced an OS benefit in the Phase III TROPiCS-02 trial, but Trodelvy faces commercial headwinds • Source: Shutterstock
More from Strategy
More from Business